| ISIN | LU1811047320 |
|---|---|
| Valor Number | |
| Bloomberg Global ID | |
| Fund Name | Bellevue Digital Health I2 USD |
| Fund Provider |
Bellevue Asset Management AG
Zürich, Switzerland Phone: +41 44 267 67 00 E-Mail: info@bellevue.ch Web: www.bellevue.ch |
| Fund Provider | Bellevue Asset Management AG |
| Representative in Switzerland |
Waystone Fund Services (Switzerland) SA Lausanne Phone: 0041213111781 |
| Distributor(s) | |
| Asset Class | Equities |
| EFC Category | |
| Distribution Policy | Accumulation |
| Home Country | Luxembourg |
| Issuing Condition | Combination of issuing commission charged by the fund management company and transaction fee charged by the fund |
| Redemption Condition | Combination of redemption commission charged by the fund management company and transaction fee charged by the fund |
| Investment Strategy *** | The Sub-fund is an actively managed equity fund. The investment objective of the sub-fund is to achieve long-term capital growth by investing at least two thirds of the net assets of the sub-fund in a portfolio of carefully chosen shares and preference shares of companies in the medical technology industry or companies whose main activity involves holding investments in such companies or financing such companies and that have their registered office or carry out the majority of their economic activity in recognised countries. |
| Peculiarities |
| Current Price * | 206.27 USD | 20.01.2026 |
|---|---|---|
| Previous Price * | 207.08 USD | 16.01.2026 |
| 52 Week High * | 211.15 USD | 25.11.2025 |
| 52 Week Low * | 166.37 USD | 08.04.2025 |
| NAV * | 206.27 USD | 20.01.2026 |
| Issue Price * | ||
| Redemption Price * | ||
| Closing Price * | ||
| Indicative Minimum Price | ||
| Fund Assets *** | 174,580,298 | |
| Unit/Share Assets *** | ||
| Trading Information SIX | ||
| YTD Performance | +3.35% |
31.12.2025 - 20.01.2026
31.12.2025 20.01.2026 |
|---|---|---|
| YTD Performance (in CHF) | +2.95% |
31.12.2025 - 20.01.2026
31.12.2025 20.01.2026 |
| 1 month | +0.71% |
22.12.2025 - 20.01.2026
22.12.2025 20.01.2026 |
| 3 months | +5.51% |
20.10.2025 - 20.01.2026
20.10.2025 20.01.2026 |
| 6 months | +8.51% |
21.07.2025 - 20.01.2026
21.07.2025 20.01.2026 |
| 1 year | +1.37% |
21.01.2025 - 20.01.2026
21.01.2025 20.01.2026 |
| 2 years | +12.48% |
22.01.2024 - 20.01.2026
22.01.2024 20.01.2026 |
| 3 years | +5.85% |
20.01.2023 - 20.01.2026
20.01.2023 20.01.2026 |
| 5 years | -31.37% |
15.06.2021 - 20.01.2026
15.06.2021 20.01.2026 |
| Equity Participation Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Share of Total Fund Assets in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Real Estate Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ADDI | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ADDI Date | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Penumbra Inc | 6.27% | |
|---|---|---|
| Intuitive Surgical Inc | 6.23% | |
| DexCom Inc | 6.12% | |
| Insulet Corp | 5.91% | |
| PROCEPT BioRobotics Corp | 5.50% | |
| Globus Medical Inc Class A | 4.58% | |
| Veeva Systems Inc Class A | 4.56% | |
| Waystar Holding Corp | 4.50% | |
| Natera Inc | 4.45% | |
| Glaukos Corp | 4.42% | |
| Last data update | 31.12.2025 | |
| TER | 1.38% |
|---|---|
| TER date | 29.01.2021 |
| Performance Fee *** | 0.00% |
| PTR | |
| Max. Management Fee *** | 0.80% |
| Ongoing Charges *** | 1.30% |
|
SRRI ***
|
|
| SRRI date *** | 31.12.2025 |